EE279 Model-Projected Long-Term Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) Gene-Edited Therapy in Patients with Transfusion-Dependent Beta-Thalassemia in the United Kingdom
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.545
https://www.valueinhealthjournal.com/article/S1098-3015(23)03675-6/fulltext
Title :
EE279 Model-Projected Long-Term Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) Gene-Edited Therapy in Patients with Transfusion-Dependent Beta-Thalassemia in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03675-6&doi=10.1016/j.jval.2023.09.545
First page :
Section Title :
Open access? :
No
Section Order :
10034